Difference between revisions of ". Neuromod Devices Closes 33.2 M Round For Neuromodulation Tech."
m |
MuhammadSjk (talk | contribs) m |
||
| Line 1: | Line 1: | ||
| − | Lenire is a bimodal neuromodulation device which works by | + | Lenire is a bimodal neuromodulation device which works by providing mild electrical pulses to the tongue, [https://www.protopage.com/seanyayo9b Bookmarks] with an intra-oral part called the 'Tonguetip ®', integrated with acoustic stimulation with earphones to drive long-term changes in the mind to deal with ringing in the ears.<br><br>Founded in 2010 by Dr. Ross 'Neill, CHIEF EXECUTIVE OFFICER, Neuromod Devices is a clinical technology company that specialises in the layout and development of neuromodulation technologies to deal with the scientific demands of underserved individual populaces who cope with chronic and incapacitating problems.<br><br>The US is a huge market, 40 per cent of the international hearing-aid market, and 50 million Americans have ringing in the ears," said Dr 'Neill, the business's creator, noting that the US division of support's department of experienced affairs is the biggest purchaser of hearing aids around the world, purchasing concerning 800,000 a year to service 1.5 million professionals with hearing loss. <br><br>The very first of these trials, TENT-A1, represents among the largest and lengthiest followed-up scientific tests ever conducted in the ringing in the ears area and was the cover tale for the scientific journal Science Translational Medicine in October 2020. |
Latest revision as of 20:14, 15 June 2024
Lenire is a bimodal neuromodulation device which works by providing mild electrical pulses to the tongue, Bookmarks with an intra-oral part called the 'Tonguetip ®', integrated with acoustic stimulation with earphones to drive long-term changes in the mind to deal with ringing in the ears.
Founded in 2010 by Dr. Ross 'Neill, CHIEF EXECUTIVE OFFICER, Neuromod Devices is a clinical technology company that specialises in the layout and development of neuromodulation technologies to deal with the scientific demands of underserved individual populaces who cope with chronic and incapacitating problems.
The US is a huge market, 40 per cent of the international hearing-aid market, and 50 million Americans have ringing in the ears," said Dr 'Neill, the business's creator, noting that the US division of support's department of experienced affairs is the biggest purchaser of hearing aids around the world, purchasing concerning 800,000 a year to service 1.5 million professionals with hearing loss.
The very first of these trials, TENT-A1, represents among the largest and lengthiest followed-up scientific tests ever conducted in the ringing in the ears area and was the cover tale for the scientific journal Science Translational Medicine in October 2020.